Marygold Companies Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Marygold Companies heeft een totaal eigen vermogen van $25.5M en een totale schuld van $3.7M, wat de schuld-eigenvermogensverhouding op 14.5% brengt. De totale activa en totale passiva bedragen respectievelijk $35.9M en $10.3M.

Belangrijke informatie

14.5%

Verhouding schuld/eigen vermogen

US$3.71m

Schuld

Rente dekkingsratio	n/a
Contant	US$17.47m
Aandelen	US$25.53m
Totaal verplichtingen	US$10.34m
Totaal activa	US$35.88m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $25.0M ) TF8 } overtreffen de korte termijn passiva ( $7.9M ).

Langlopende schulden: De kortetermijnactiva TF8 ( $25.0M ) overtreffen de langetermijnschulden ( $2.5M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: TF8 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van TF8 is de afgelopen 5 jaar gestegen van 5.8% naar 14.5%.

Schuldendekking: De operationele kasstroom van TF8 is negatief, waardoor de schuld niet goed gedekt is.

Rentedekking: Er zijn onvoldoende gegevens om te bepalen of de rentebetalingen van TF8 op haar schulden goed worden gedekt door EBIT.

Marygold Companies Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

First quarter 2025 earnings released: US$0.039 loss per share (vs US$0.012 loss in 1Q 2024)

The Marygold Companies, Inc. (NYSEAM:MGLD) acquired 7.95% stake in Midland Capital Holdings Corp. for $1.8 million.

New minor risk - Shareholder dilution

Full year 2024 earnings released: US$0.10 loss per share (vs US$0.029 profit in FY 2023)

Chairman recently bought €99k worth of stock

Third quarter 2024 earnings released: US$0.013 loss per share (vs US$0.004 profit in 3Q 2023)

Now 27% overvalued after recent price rise

Now 31% overvalued after recent price rise

Now 40% overvalued after recent price rise

Second quarter 2024 earnings released: US$0.029 loss per share (vs US$0.005 profit in 2Q 2023)

Now 25% undervalued after recent price drop

Insufficient new directors

The Marygold Companies, Inc. Announces the Resignation of Stuart P. Crumbaugh as Chief Financial Officer

The Marygold Companies, Inc. Announces the Resignation of Stuart P. Crumbaugh from the Board of Directors

Investor sentiment improves as stock rises 17%

The Marygold Companies, Inc., Annual General Meeting, Nov 17, 2023

Full year 2023 earnings released: EPS: US$0.029 (vs US$0.029 in FY 2022)

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 18%

The Marygold Companies, Inc. Appoints Ian Gass as Chief Product Officer in the UK

Investor sentiment improves as stock rises 15%

Investor sentiment deteriorates as stock falls 18%

Third quarter 2023 earnings released: EPS: US$0.004 (vs US$0.022 in 3Q 2022)

Investor sentiment deteriorates as stock falls 15%

Investor sentiment improves as stock rises 16%

Second quarter 2023 earnings released: EPS: US$0.005 (vs US$0.027 in 2Q 2022)

Insufficient new directors

The Marygold Companies, Inc., Annual General Meeting, Nov 11, 2022

Full year 2022 earnings released: EPS: US$0.029 (vs US$0.15 in FY 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Chairman recently bought €122k worth of stock

Third quarter 2022 earnings released: EPS: US$0.022 (vs US$0.042 in 3Q 2021)

Insufficient new directors

Investor sentiment improved over the past week

Insufficient new directors

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven